Medicinal discovery for innovative treatment of auto-immune diseases and inflammatory diseases caused by immune dys-regulation. Laboratory for innovative drug discovery in the well-validated JAK-STAT pathway, with a specialty in a novel mode of molecular therapeutic intervention. Rapid progression along the R&D path driven by industry-savvy founders, including ex-Pfizer R&D executive as our CEO.